Boston Scientific’s (BSX) Bleak Outlook
The stent business continues to dog Boston Scientific (BSX) numbers. Several studies have shown that the devices can cause blood clots. BSX sales for the third quarter of 2007 were $2.048 billion as compared…
The stent business continues to dog Boston Scientific (BSX) numbers. Several studies have shown that the devices can cause blood clots. BSX sales for the third quarter of 2007 were $2.048 billion as compared…
Markets in Europe were lower at 6.20 AM New York time. The FTSE was off .1% to 6,602. BP (BP) was up 1.2% to 623.5. Nothern Rock was down 2.2% to 200. The DAXX…
Sen. Charles Schumer seems to have his nose everywhere, whether it belongs or not. Yesterday, he called for the SEC to investigate Countrywide (CFC) along with its CEO CEO Angelo Mozilo. There is some…
Several banks with troubled fixed income and mortgage securities are making the rounds to raise $80 billion to $100 billion to build a fund to buy some of this distressed debt. Citicorp (C) has…
AMD (AMD) had another big quarterly loss. But, it was not as large as in Q2 and gross margins improved a bit. Maybe the chip price wars are ending and AMD can move back…
Google (GOOG) has made believers out of everyone. It is worth every penny of its $640 share price. According to a survey by Barron’s, several large firms including Credit Suisse and Goldman Sachs have…
According to Reuters, Google’s (GOOG) quarterly profit rose 46%. Reuters writes that Warren Buffett has sold his entire stake in PetroChina (PTR) Reuters writes that Microsoft (MSFT) says that its may make a number…
Markets in Asia were mixed and Hong Kong was closed for a holiday. The Nikkei fell 1.7% to 16,814. Kobe Stell fell 3.7% to 422. Sony (SNE) fell 2% to 5320. Yahoo Japan rose…
New video game "Halo 3" was supposed to give sales of Microsoft’s (MSFT) Xbox 360 game console a leg up. But, things got out of hand. According to MarketWatch, figures "from NPD Group video…
Intuitive Surgical Inc. (NASDAQ:ISRG) saw shares rise a monster 8.3% to $256.44 in active trading ahead of earnings. After the earnings report, it appears shares are trading up another 4.9% in after-hours at $269.00…
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI) Housing and mortgage markets hurt quarter. Falls to $22.80 from 52-week high of $51.46.…
PMC-Sierra, Inc. (NASDAQ:PMCS) posted earnings of $0.09 on non-GAAP EPS on net revenues of $117.5 million, versus estimates of $0.06 EPS and $113.7 million. On a GAAP basis the company posted -$0.03 EPS. The…
Sandisk (SNDK) the world’s largest supplier of flash storage card products, announced third quarter revenue increased 38% on a year-over-year basis to $1.037 billion and net income increased to $85 million, or $0.36 per…
Investors hoped for big thing from AMD (AMD) moving shares up over 3% in the regular session to $14.56. Analysts were looking for AMD to report a loss per share of 62 cents on…
Google’s (NASDAQ:GOOG) earnings are out: $3.91 EPS and Revenues were $3.01 Billion; First Call estimates on last look were $3.78 EPS and $2.94 Billion in revenues. The revenue number is on an ex-Traffic Acquisition…
One of the companies mentioned in the 24/7 Wall St. piece on September financial website numbers sent along some additional information. That is time spent per person per month at each site. For September:…
Tonight’s headlines are going to be dominated by one event… Google’s (NASDAQ:GOOG) earnings. First Call estimates on last look were $3.78 EPS and $2.94 Billion in revenues. The revenue number is on an ex-Traffic…
Dear Dr.Schmidt: Google Finance currently ranks 18th among all financial websites with 851,000 unique visitors in September. That puts it behind sites like The Motley Fool and Bloomberg. MSN Money had 10.9 million unique…
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug Exubera and return the licensing rights to…
Brutal, IMS (RX) shares are selling off 25% to $21.80, a 52-week low Bad earnings followed by downgrades. IMS Health which is a provider of market intelligence to the pharmaceutical and healthcare industries, announced…